The mammalian FoxO (forkhead box O) transcription factors FoxO1, FoxO3 and FoxO4 represent one of several effector arms of the PI3K (phosphoinositide 3-kinase)-Akt signalling network that has been linked to cancer, metabolism and aging. Specific roles of the FoxOs in the vascular cell types have been investigated to reveal that they play redundant yet critical roles in the proliferation and survival of ECs (endothelial cells). Somatic deletions of all FoxOs engendered progressive, widespread and highly penetrant haemangiomas associated with altered proliferative/survival dynamics of ECs in our genetic model. Related work by AktFoxO manipulation reported differentially regulated genes in ECs that may represent novel FoxO targets, controlling EC growth and morphogenesis and mediating many of the consequences of FoxO inactivation in the endothelium. Further studies on the action of these surrogate genes may provide important new insights into how the PI3K-Akt-FoxO pathway could be exploited clinically to treat vascular diseases and lead to the invention of novel therapeutic approaches. Here recent studies elucidating the role of FoxOs in the maintenance of vascular homoeostasis and supporting that the mammalian FoxO family serves essential roles in the maintenance of vascular stability and the suppression of aberrant vascular outgrowth are discussed.
FoxO (forkhead box O) transcription factors as PI3K (phosphoinositide 3-kinase)-Akt downstream effectors play general roles in cell-cycle inhibition and stress response
The FoxO family of transcription factors belong to the winged helix or forkhead box class of transcription factors [1] , which have been identified in organisms ranging from yeast to human. Mice and humans possess four known FoxO members: FoxO1 [previously known as FKHR (forkhead in rhabdosarcoma)], FoxO3 (FKHRL1), FoxO4 (AFX), and a more recently discovered member, FoxO6 [2] [3] [4] [5] [6] [7] . The presence of multiple FoxOs in mammals suggests functional redundancy and diversification among the FoxOs.
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The analysis of FoxO function in mammalian cells has extended insights derived from Caenorhabditis elegans systems and has forged their role in governing cell survival, cellcycle regulation and DNA repair, among other processes. Specifically, constitutively active FOXOs can promote apoptosis in a number of cell types, correlating with both upregulation of the death cytokine Fas ligand [9, 22, 23] and proapoptotic Bcl-2 member Bim [24, 25] , and down-regulation of the pro-survival factor Bcl-X L by FoxO4, which may be mediated through the up-regulation of the transcriptional repressor Bcl-6 [26] . In cell-cycle regulation, enforced FOXO expression results in G 1 arrest mediated in part through increased expression of the cyclin-dependent kinase inhibitor p27 KIP [27] as well as down-regulation of D-type cyclins [28] . FOXO proteins have also been implicated in the induction of the quiescent G 0 state, an observation in accord with the ability of FoxO to directly regulate transcription of the p130 pocket protein [29] . Finally, FOXO overexpression can also cause a delay in the G 2 -M transition, likely mediated through FoxO-dependent regulation of Gadd45a (growth-arrest and DNA-damage-inducible protein 45a) [30, 31] . Since Gadd45a is involved in DNA repair, this observation has led to the speculation that FoxO factors participate in DNA damageinduced cell-cycle arrest and in the activation of genes involved in DNA repair. The FoxOs have also been linked to NF-κB (nuclear factor κB) and TGF-β (transforming growth factor-β) pathways. The IκB (inhibitory κB) kinase has been shown to phosphorylate and inhibit the function of FoxO factors, and this interaction may help to rationalize some of the growth-promoting properties of IκB kinase [32] . Association with Smad proteins, which are activated by TGF-β signalling, enhances transcription of the cell-cycle inhibitor p21 CIP by FoxOs [33] . FoxO factors in mammals may promote stress resistance. Ectopic expression of the constitutively active FOXO3 in mammalian cells results in increased reactive oxygen species scavenging and cell survival in response to oxidative stress, and increases in mitochondrial manganese superoxide dismutase 2 and catalase levels may play a part in these results [34] [35] [36] . FOXO is acetylated in response to cellular stress by the acetyl transferase activity of the nuclear hormone receptor co-activators CBP [CREB (cAMP-response-elementbinding protein)-binding protein] and p300. On the other hand, expression of SIRT1 causes FOXO deacetylation [37, 38] . While the implications of these FoxO modifications are not yet well understood, it appears overall that deacetylation by SIRT1 functions to promote cell survival under oxidative stress while inhibiting apoptosis, all by affecting the transcriptional activity of FoxO. DePinho, unpublished work). Mice upon losing all three FoxOs developed widespread haemangioma, reminiscent of one of the PTEN germline mutation syndromes, BannayanZonana [40] . This manifested phenotype, together with the findings reported recently by others, highlights the roles of the PI3K-Akt-FoxO pathway in angiogenesis and the growth and survival of ECs (endothelial cells), suggesting that dysregulation of this pathway might be the culprit for the formation of aberrant vasculature present in diseased tissues including cancer. Indeed the role of FoxO as a critical gatekeeper of EC proliferation was deduced in benign liver haemangiomas associated with TSC2 (tuberous sclerosis complex 2) deficiency. Nuclear FOXO due to inactivation of the Akt pathway, a signature of TSC2-null cells, was speculated to be the major barrier to the development of aggressive haemangiosarcoma. Correspondingly, TSC2 deficiency in a Pten +/− background leads to very aggressive lethal haemangiomas wherein FOXOs localize to the cytosol [41] .
FoxOs in the vascular biology
Importance of FoxOs in the development of vascular system was shown by an initial effort to discover in vivo function of FoxO1. Germline knockout of FoxO1 caused embryonic lethality (E10.5) due to defects in vasculogenesis [42] . Although this speaks for the dominant role of FoxO1 in ECs considering the redundant expression and function of FoxO family in many cell types, it is counterintuitive based on the predicted role for FoxO given its inhibition by the PI3K-Akt pathway. Specifically, FoxO1-deficient ECs showed a markedly different morphological response compared with wild-type ECs in the presence of exogenous VEGF (vascular endothelial growth factor). These results suggest that FoxO1 is essential to the ability of ECs to respond properly to a high dose of VEGF, thereby playing a critical role in normal vascular development [42, 43] 
level of specificity given to the specific lineage of cell types where they are expressed [43] . Our laboratory, instead, took advantage of conditional knockout mice that provided a unique opportunity to appreciate the role of FoxO factors in the adult vasculature. Unlike germline knockout approaches that cannot address critical functions of FoxOs due to early lethality and compensation during the course of development, acute challenge of animals with defined spatiotemporal deletion of FoxO brought out importance of other FoxOs in the postnatal animals. Of importance, systematic occurrence of haemangioma in triply null FoxO animals was limited to certain tissue types (i.e. uterus, liver and muscle) where vascular remodelling tendency is pertinent. Again, much less severe lesions were observed in FoxO1 singlenull animals but not in FoxO3 or FoxO4 nullizygous mice, arguing that FoxO1 is the most physiologically important regulator of endothelial stability. Nonetheless, additional inactivation of FoxO3 and/or FoxO4 to FoxO1 resulted in more severe haemangioma phenotypes, clearly indicating that both FoxO3 and FoxO4 also contribute to endothelial growth suppression [39] . These speak for a possibility that challenging animals with relevant stresses may further reveal a unique role of each FoxO in adult vascular bed.
The precise mode of action by FoxOs in the course of angiogenesis, however, has not been fully explored. Nevertheless, the PI3K-Akt pathway has been found to be critical to angiogenesis, promoting EC survival in response to VEGF [44, 45] . Of interest, key effectors of PI3K-Akt action in ECs, including eNOS (endothelial nitric oxide synthase) and HIF-1 (hypoxia-inducible factor-1), have been implicated as direct targets of FoxO action. Expression of eNOS promotes survival of ECs through caspase inactivation, which was shown to be suppressed by constitutively active FOXO1 and FOXO3 [46] . HIF-1, a master regulator of hypoxia-induced angiogenesis, was shown to be up-regulated by PI3K-Akt activation but its expression was suppressed by FOXO4 in a non-canonical pVHL (von Hippel-Lindau protein)-independent manner [47] . Together, these suggest that there are multiple routes of regulation on angiogenesis diverging from upstream of Akt, as some funnel through FoxO arm of regulation and converge at the critical regulators of angiogenic responses.
Recent reports suggest that FoxOs have a role in angiogenesis and postnatal neovascularization. As a proof of concept, several studies demonstrated that FoxOs modulate EC proliferation and survival using pharmacological approaches under controlled, in vitro conditions. For example, pro-angiogenic eicosanoids were shown to inhibit p27 KIP expression without affecting p21CIP level in human umbilicalvein ECs [48] . This was mediated by Akt-dependent phosphorylation and inhibition of FOXO1 and FOXO3. Expression of dominant-active mutant FOXO3 that is refractory to PI3K-Akt activation or down-regulation of FOXOs by RNAi (RNA interference) demonstrated that eicosanoids-induced angiogenic response is mainly mediated by the relief from inhibition of cell-cycle progression by FoxOs. Aortic EC proliferation induced by the C5b-9 complement complex, which has been implicated in the prelesional stage of atherogenesis and progression of atherosclerotic lesion, was shown to be mediated by the PI3K-Akt pathway and accompanied the inactivation of FOXO1 [49] . Moreover, increased expression of HSP70 (heat-shock protein 70) by enforced expression of Akt in EC was suppressed by FOXO3 expression [50] . Vice versa FOXO3-induced, caspase9-dependent apoptosis of EC was inhibited by co-expression of HSP70. This agrees with the idea that FoxO controls cellular viability through modulation of the stress-induced intrinsic cell death pathway. Furthermore, enforced expression of FOXO1 or FOXO3 but not FOXO4 inhibited in vitro angiogenic properties of ECs including migration and morphogenesis on Matrigel in response to angiogenic cytokines. Loss-of-function studies using RNAi for FoxO1 and FoxO3 revealed that these two factors regulate overlapping but unique sets of genes that can inhibit various growth and angiogenesis-related transcriptional networks and processes [46, 51] . Of note, the importance of FoxO as a mediator of critical signalling pathways within EC has been convincingly demonstrated. ANG-1 (angiopoietin-1), a regulator of blood vessel stability as well as mediator of vascular development, was shown to regulate the expression of genes critical to EC survival and vessel stability through modulation of FoxO1 [51] . ANG-1 inhibits FoxO1-mediated gene expression and accompanying EC apoptosis. Genes commonly shown to be regulated by FoxO factors in ECs in our study as well as others are Id-1, Esm-1 (EC-specific molecule), Ang-2, Ctgf (connective tissue growth factor) and Egr-1 (early growth response-1) among others [39, 46, 51] . Detailed characterization of how these genes execute EC fate given by FoxO warrants future study. FoxO4 that does not have an apparent role in regular ECs regulates EPC (endothelial progenitor cells), a cell type implicated in adult neovascularization. Enforced expression of FOXO4 induced expression of Bim, a pro-apoptotic gene, which leads to an increase in apoptosis of EPCs. Along these lines oxidative stress-induced apoptosis of EPCs was prevented when cells were treated with VEGF or statins (3-hydroxy-3-methylglutaryl-CoA reductase inhibitors), both are known protectors of vascular endothelium. Mechanism of protection was shown in part through inhibition of FOXO4 by phosphorylation and sequestration in the cytosol [52] .
Of great relevance to the maintenance of the vascular system, a critical role of FoxO4 in VSMC (vascular smooth cell) differentiation and proliferation has been explored, which was not evident by germline deletion approaches. As VSMC is the major cell type contributing to pathological progression into atherosclerosis, postangioplasty restenosis and transplant vasculopathy, understanding the role of FoxOs in their regulation is an important subject. Initial investigation was focused on IGF-1 (insulin-like growth factor-1)-induced differentiation of VSMC. As FOXO4 is being phosphorylated by the PI3K-Akt axis, its interaction with myocardin, a critical transcriptional co-activator for genes for differentiation into VSMC, was demonstrated to be affected. Nuclear export of FOXO4 induced by extracellular cues de-represses myocardin and in turn leads to VSMC differentiation [53] . Furthermore, cell-cycle changes induced by phosphorylation and nuclear exclusion of FOXOs by PDGF (platelet-derived growth factor), tumour necrosis factor α, and IGF-1 stimulation of aortic VSMC were demonstrated [54] . In particular, this led to a decrease in p27 KIP level by PDGF that correlates with proliferation of VSMC. Expression of phosphorylation-defective form of FOXO3 (TM-FKHRL1) reversed its expression, establishing p27 KIP as a downstream surrogate marker of FoxO activation in the VSMC compartment. Furthermore, adenoviral gene delivery of FoxO3 in rat balloon injury model caused an increase in the expression of p27 KIP in the VSMC and an inhibition of neointimal hyperplasia [54] . Together, FoxO activity inhibits VSMC proliferation, presenting FoxO as a potential therapeutic target in vascular diseases. Whether inactivation of FoxOs in VSMC or pericytes, both cell types necessary for the maintenance of stable vasculature, contributes to destabilization of blood vessels or uncoupling of cell-cell contact between ECs and VSMC under pathological condition is open for investigation. Nevertheless, transcriptional regulation of ANG-2 expression by FoxOs speaks for their role in the regulation of vascular maturation and vessel homoeostasis [46] .
Undoubtedly investigating the role of FoxO in vascular homoeostasis would lead to a better understanding of these transcription factors in intricate control of EC and VSMC behaviour. Finally, there are promises of new therapeutic approaches to the vascular insufficiency and uncontrolled proliferation of vascular cell types by targeting downstream of PI3K-Akt-FoxO loop. Much work remains to be done to elucidate FoxOs' relevance to the overall health of mammals, and the knowledge gained from these studies may provide important insights into the mechanisms governing aging and cancer where FoxO was originally recognized. 
